# EDGAR Filing Document

**Accession Number:** 0000095574
**File Stem:** 0001437749-26-014539
**Filing Date:** 2026-5
**Character Count:** 22936
**Document Hash:** 660b7253b298b8249743e859e2d4b490
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-26-014539.hdr.sgml**: 20260504

**ACCESSION NUMBER**: 0001437749-26-014539

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 39

**CONFORMED PERIOD OF REPORT**: 20260504

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260504

**DATE AS OF CHANGE**: 20260504

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SUPERIOR GROUP OF COMPANIES, INC.
- **CENTRAL INDEX KEY:** 0000095574
- **STANDARD INDUSTRIAL CLASSIFICATION:** APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 111385670
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-05869
- **FILM NUMBER:** 26934594

**BUSINESS ADDRESS:**
- **STREET 1:** 200 CENTRAL AVENUE, SUITE 2000
- **CITY:** ST. PETERSBURG
- **STATE:** FL
- **ZIP:** 33701
- **BUSINESS PHONE:** 7273979611

**MAIL ADDRESS:**
- **STREET 1:** 200 CENTRAL AVENUE, SUITE 2000
- **CITY:** ST. PETERSBURG
- **STATE:** FL
- **ZIP:** 33701

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SUPERIOR UNIFORM GROUP INC
- **DATE OF NAME CHANGE:** 19980810

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SUPERIOR SURGICAL MANUFACTURING CO INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? sgc20260323_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

**FORM**8-K**

**CURRENT REPORT**

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) <u>May 4, 2026</u>

**<u>Superior Group of Companies, Inc.</u>**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **<u>Florida</u>** | **<u>001-05869</u>** | **<u>11-1385670</u>** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **<u>200 Central Avenue, Suite 2000</u><u>, <u><u><u>**<u>St. Petersburg</u>**</u></u></u>, <u><u><u>**<u>Florida</u>**</u>**</u></u></u><br> (Address of principal executive offices) | **<u>33701</u>**<br> (Zip Code) |

---

Registrant's telephone number including area code: **<u>(<u><u><u>**<u>727</u>**</u></u></u>) <u><u><u>**<u>397-9611</u>**</u>**</u></u></u>

<u>**Not Applicable**</u>

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock | SGC | NASDAQ |

---

------

**Item 2.02 Results of Operations and Financial Condition**

The following information is being furnished under Item 2.02 of Form 8-K: Press release by Superior Group of Companies, Inc. (the "Company") announcing its results of operations for the quarter ended March 31, 2026. A copy of this press release is attached as Exhibit 99.1 to this Form 8-K.

**Item 9.0l Financial Statements and Exhibits**

(d) Exhibits

---

| | |
|:---|:---|
| <u>Exhibit Number</u> | <u>Description</u> |
| 99.1 | [Press Release, dated May 4, 2026](ex_936064.htm) |
| 99.2 | [Investor Presentation, dated May 4, 2026](ex_954041.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Signature**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunder duly authorized.

---

| | |
|:---|:---|
| SUPERIOR GROUP OF COMPANIES, INC. | SUPERIOR GROUP OF COMPANIES, INC. |
| By:  | /s/ Michael Koempel |
|  | Michael Koempel |
|  | President & Chief Financial Officer |

---

Date: May 4, 2026

## Exhibit 99.1

**Exhibit 99.1**

![logo01.jpg](logo01.jpg)

FOR IMMEDIATE RELEASE

**SUPERIOR GROUP OF COMPANIES REPORTS FIRST QUARTER 2026 RESULTS**

---

| |
|:---|
| ***– Total net sales of $140.9 million, compared to $137.1 million in prior year first quarter*** – |
| ***– Net income of $0.8 million, up from a net loss of ($0.8) million in prior year first quarter*** – |
| ***– EBITDA of $4.8 million, up from $3.5 million in prior year first quarter*** – |
| ***– Confirms full-year Outlook -*** |
| ***– Board of Directors approves $0.14 per share quarterly dividend*** – |

---

ST. PETERSBURG, Fla., May 4, 2026 – Superior Group of Companies, Inc. (NASDAQ: SGC) (the "Company"), today announced its first quarter 2026 results.

"Against a still uncertain economic backdrop, our first quarter results show that we are continuing to move Superior Group of Companies in the right direction, even as there is still work to reach the level of performance we are targeting," said Michael Benstock, Chief Executive Officer. "We are seeing the benefits of the portfolio and cost actions we've taken over the last several years, with healthier business mix, improved underlying profitability and stronger earnings power than a year ago, despite uneven demand across our end markets. While macro and geopolitical conditions remain difficult to predict and are weighing on customer spending in certain categories, our diversified segments, strong customer relationships and flexible supply chain position us to continue taking share where we choose to compete. Consistent with the historical cadence of our business, we expect performance to be more heavily weighted to the back half of 2026, and our balance sheet and cash generation give us the ability to keep investing in our most differentiated solutions while returning capital to shareholders through our dividend and opportunistic share repurchases in support of long-term value creation."

<u>First Quarter Results</u>

For the first quarter ended March 31, 2026, net sales were $140.9 million, compared to first quarter 2025 net sales of $137.1 million. Pretax earnings of $1.1 million compared to ($0.9) million in the first quarter of 2025. Net earnings of $0.8 million or $0.06 per diluted share compared to a net loss of ($0.8) million or ($0.05) per diluted share for the first quarter of 2025.

<u>First Quarter 2026 Dividend</u>

The Board of Directors declared a quarterly dividend of $0.14 per share, payable May 29, 2026 to shareholders of record as of May 15, 2026.

<u>2026 Full-Year Outlook</u>

The Company continues to forecast full-year 2026 net sales in the range of $572 million to $585 million, up from 2025 net sales of $566.2 million, and full-year earnings per diluted share in the range of $0.54 to $0.66, up from $0.46 in 2025.

------

**Webcast and Conference Call**

The Company will host a webcast and conference call at 8:00am Eastern Time today. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/Presentations. Interested individuals may also join the teleconference by dialing 1-844-861-5505 for U.S. dialers and 1-412-317-6586 for International dialers. The Canadian toll-free number is 1-866-605-3852. Please ask to be joined to the Superior Group of Companies call. A telephone replay of the teleconference will be available through May 11, 2026. To access the replay, dial 1-855-669-9658 in the United States or Canada, or 1-412-317-0088 from international locations. Please reference conference number 4789430 for replay access.

**Disclosure Regarding Forward Looking Statements**

*Certain matters discussed in this press release are* "*forward-looking statements*" *intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words* "*may,*" "*will,*" "*should,*" "*could,*" "*expect,*" "*anticipate,*" "*estimate,*" "*believe,*" "*intend,*" "*project,*" "*potential,*" *or* "*plan*" *or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release may include, without limitation: (1) projections of revenue, income, and other items relating to our financial position and results of operations, including short term and long term plans for cash, (2) statements of our plans, objectives, strategies, goals and intentions, (3) statements regarding the capabilities, capacities, market position and expected development of our business operations and (4) statements of expected industry and general economic trends.*

*Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the following: the impact of competition; uncertainties related to tariffs, duties, trade wars and related matters, supply disruptions, inflationary environments (including with respect to shipping costs and the cost of finished goods and raw materials and shipping costs), employment levels (including labor shortages), and general economic and political conditions in the areas of the world in which the Company operates or from which it sources its supplies or the areas of the United States of America (*"*U.S.*" *or* "*United States*"*) in which the Company*'*s customers are located; changes in the healthcare, retail chain, food service, transportation and other industries where uniforms and service apparel are worn; our ability to identify suitable acquisition targets, discover liabilities associated with such businesses during the diligence process, successfully integrate any acquired businesses, or successfully manage our expanding operations; the price and availability of raw materials; attracting and retaining senior management and key personnel; the Company's ability to maintain effective internal control over financial reporting; and other factors described in the Company*'*s filings with the Securities and Exchange Commission ("SEC"), including those risks described in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 entitled "Risk Factors" and the Quarterly Report on Form 10-Q for the quarter ended March 31, 2026. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we disclaim any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.*

**About Superior Group of Companies, Inc. (SGC):**

Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC's commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. We are committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit www.superiorgroupofcompanies.com.

**Investor Relations Contact:**<br> Investors@Superiorgroupofcompanies.com

------

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES <br> CONSOLIDATED STATEMENTS OF OPERATIONS <br> (Unaudited)

(In thousands, except shares and per share data)

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | 2026 | 2025 |
| Net sales | $140878 | $137097 |
| Costs and expenses: |  |  |
| Cost of goods sold | 88544 | 86656 |
| Selling and administrative expenses | 50368 | 50102 |
| Interest expense, net | 912 | 1245 |
|  | 139824 | 138003 |
| Income (loss) before income tax expense (benefit) | 1054 | (906) |
| Income tax expense (benefit) | 220 | (148) |
| Net income (loss) | $834 | $(758) |
| Net income (loss) per share: |  |  |
| Basic | $0.06 | $(0.05) |
| Diluted | $0.06 | $(0.05) |
| Weighted average shares outstanding during the period: |  |  |
| Basic | 14629019 | 15599655 |
| Diluted | 14917845 | 15599655 |
| Cash dividends per common share | $0.14 | $0.14 |

---

------

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES <br> CONSOLIDATED BALANCE SHEETS <br> (In thousands, except shares and par value data)

---

| | | |
|:---|:---|:---|
|  | March 31, | December 31, |
|  | 2026 | 2025 |
|  | (Unaudited) |  |
| <u>ASSETS</u> |  |  |
| Current assets: |  |  |
| Cash and cash equivalents | $23172 | $23691 |
| Accounts receivable, net | 84917 | 104336 |
| Inventories | 97430 | 97474 |
| Contract assets | 55313 | 48903 |
| Prepaid expenses and other current assets | 13903 | 13259 |
| Total current assets | 274735 | 287663 |
| Property, plant and equipment, net | 35966 | 37352 |
| Operating lease right-of-use assets | 12157 | 12620 |
| Deferred tax asset | 14987 | 15003 |
| Intangible assets, net | 46359 | 47254 |
| Goodwill | 2583 | 2583 |
| Other assets | 19734 | 19369 |
| Total assets | $406521 | $421844 |
| <u>LIABILITIES AND SHAREHOLDERS' EQUITY</u> |  |  |
| Current liabilities: |  |  |
| Accounts payable | $45159 | $48343 |
| Other current liabilities | 48324 | 53041 |
| Current portion of long-term debt | 7031 | 6563 |
| Total current liabilities | 100514 | 107947 |
| Long-term debt | 80279 | 87093 |
| Long-term pension liability | 15123 | 15010 |
| Long-term acquisition-related contingent liabilities | 919 | 826 |
| Long-term operating lease liabilities | 7586 | 7939 |
| Other long-term liabilities | 9349 | 10211 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total liabilities | 213770 | 229026 |
| Shareholders' equity: |  |  |
| Preferred stock, $.001 par value - authorized 300,000 shares (none issued) |  |  |
| Common stock, $.001 par value - authorized 50,000,000 shares, issued and outstanding 15,632,981 and 15,730,615 shares, respectively | 16 | 16 |
| Additional paid-in capital | 84857 | 84628 |
| Retained earnings | 111233 | 112871 |
| Accumulated other comprehensive loss, net of tax: | (3355) | (4697) |
| Total shareholders' equity | 192751 | 192818 |
| Total liabilities and shareholders' equity | $406521 | $421844 |

---

------

---

| |
|:---|
| SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES |
| CONSOLIDATED STATEMENTS OF CASH FLOWS |
| (Unaudited) |
| (In thousands) |

---

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | 2026 | 2025 |
| CASH FLOWS FROM OPERATING ACTIVITIES |  |  |
| Net income (loss) | $834 | $(758) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |  |  |
| Depreciation and amortization | 2858 | 3204 |
| Inventory write-downs | 1095 | 441 |
| Credit loss expense | 314 | 131 |
| Share-based compensation expense | 887 | 1283 |
| Change in fair value of acquisition-related contingent liabilities | 93 | 287 |
| &nbsp;&nbsp;&nbsp; Non-cash operating lease expense | 1019 | 900 |
| Other, net | 46 | 86 |
| &nbsp;&nbsp;&nbsp; Changes in assets and liabilities: |  |  |
| Accounts receivable | 19415 | 2607 |
| Contract assets | (6397) | 1069 |
| Inventories | (994) | (2191) |
| Prepaid expenses and other current assets | 159 | 749 |
| Other assets | (391) | 113 |
| Accounts payable and other current liabilities | (9044) | (9262) |
| Other long-term liabilities | (537) | (647) |
| Net cash provided by (used in) operating activities | 9357 | (1988) |
| CASH FLOWS FROM INVESTING ACTIVITIES |  |  |
| Additions to property, plant and equipment | (568) | (1131) |
| Net cash used in investing activities | (568) | (1131) |
| CASH FLOWS FROM FINANCING ACTIVITIES |  |  |
| Borrowings under revolving lines of credit | 10000 | 19000 |
| Payments under revolving lines of credit | (15000) | (8000) |
| Payments of term loan | (1406) | (1406) |
| Payments of cash dividends | (2164) | (2280) |
| Shares withheld for taxes net of proceeds received on exercise of stock options | (288) | 87 |
| Common shares repurchased and retired | (678) | (3777) |
| Net cash (used in) provided by financing activities | (9536) | 3624 |
| Effect of currency exchange rates on cash | 228 | 486 |
| Net decreases in cash and cash equivalents | (519) | 991 |
| Cash and cash equivalents balance, beginning of period | 23691 | 18766 |
| Cash and cash equivalents balance, end of period | $23172 | $19757 |

---

------

---

| |
|:---|
| SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES |
| NON-GAAP FINANCIAL MEASURES |
| (Unaudited) |
| (In thousands) |

---

---

| | | |
|:---|:---|:---|
|  | Three Months Ended March 31, | Three Months Ended March 31, |
|  | 2026 | 2025 |
| Net income (loss) | $834 | $(758) |
| Interest expense, net | 912 | 1245 |
| Income tax expense (benefit) | 220 | (148) |
| Depreciation and amortization | 2858 | 3204 |
| EBITDA(1) | $4824 | $3543 |
| EBITDA margin(1) | 3.4% | 2.6% |

---

(1) EBITDA, which is a non-GAAP financial measure, is defined as net income excluding interest expense, net, income tax expense and depreciation and amortization expense. EBITDA margin is defined as EBITDA divided by net sales. The Company believes EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the Company's core operating results from period to period by removing (i) the impact of the Company's capital structure (interest expense from outstanding debt), (ii) tax consequences and (iii) asset base (depreciation and amortization). The Company uses EBITDA internally to monitor operating results and to evaluate the performance of its business. In addition, the compensation committee has used EBITDA in evaluating certain components of executive compensation, including performance-based annual incentive programs. EBITDA is not a measure of financial performance under GAAP. EBITDA should not be considered in isolation or as an alternative to net income, cash flows from operating activities or any other measure determined in accordance with GAAP. The items excluded to calculate EBITDA are significant components in understanding and assessing the Company's results of operations. The Company's EBITDA may not be comparable to a similarly titled measure of another company because other entities may not calculate EBITDA in the same manner.

------

---

| |
|:---|
| SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES |
| SUPPLEMENTAL INFORMATION - REPORTABLE SEGMENTS |
| (Unaudited) |
| (In thousands) |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | Branded Products | Healthcare Apparel | Contact Centers | Intersegment Eliminations | Other | Total |
| For the Three Months Ended March 31, 2026: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Net sales | $90869 | $28601 | $22253 | $(845) | $- | $140878 |
| &nbsp;&nbsp;&nbsp; Cost of goods sold | 59882 | 18420 | 10639 | (397) |  | 88544 |
| &nbsp;&nbsp;&nbsp; Gross margin | 30987 | 10181 | 11614 | (448) |  | 52334 |
| &nbsp;&nbsp;&nbsp; Selling and administrative expenses | 24746 | 10778 | 9563 | (448) | 5729 | 50368 |
| Depreciation and amortization | 1374 | 823 | 588 |  | 73 | 2858 |
| Segment EBITDA(1) | $7615 | $226 | $2639 | $- | $(5656) | $4824 |
|  | Branded Products | Healthcare Apparel | Contact Centers | Intersegment Eliminations | Other | Total |
| For the Three Months Ended March 31, 2025: |  |  |  |  |  |  |
| Net sales | $86474 | $27263 | $24225 | $(865) | $- | $137097 |
| Cost of goods sold | 58787 | 17130 | 11244 | (505) |  | 86656 |
| Gross margin | 27687 | 10133 | 12981 | (360) |  | 50441 |
| Selling and administrative expenses | 23420 | 9526 | 10921 | (360) | 6595 | 50102 |
| &nbsp;&nbsp;&nbsp; Depreciation and amortization | 1480 | 912 | 722 |  | 90 | 3204 |
| &nbsp;&nbsp;&nbsp; Segment EBITDA(1) | $5747 | $1519 | $2782 | $- | $(6505) | $3543 |

---

(1) Segment EBITDA is our primary measure of segment profitability under U.S. GAAP ASC 280 "Segment Reporting". Amounts included in income before income tax expense and excluded from Segment EBITDA include: interest expense, net and depreciation and amortization expense. Total EBITDA is a non-GAAP financial measure. Please see reconciliation of Total EBITDA included in the Non-GAAP Financial Measures table above.

## Exhibit 99.2

**Exhibit 99.2**

![slide01.jpg](slide01.jpg)

------

![slide02.jpg](slide02.jpg)

------

![slide03.jpg](slide03.jpg)

------

![slide04.jpg](slide04.jpg)

------

![slide05.jpg](slide05.jpg)

------

![slide06.jpg](slide06.jpg)

------

![slide07.jpg](slide07.jpg)

------

![slide08.jpg](slide08.jpg)

------

![slide09.jpg](slide09.jpg)

------

![slide10.jpg](slide10.jpg)

------

![slide11.jpg](slide11.jpg)

------

![slide12.jpg](slide12.jpg)

------

![slide13.jpg](slide13.jpg)

------

![slide14.jpg](slide14.jpg)

------

![slide15.jpg](slide15.jpg)

------

![slide16.jpg](slide16.jpg)

------

![slide17.jpg](slide17.jpg)

------

![slide18.jpg](slide18.jpg)

------

![slide19.jpg](slide19.jpg)

------

![slide20.jpg](slide20.jpg)

------

![slide21.jpg](slide21.jpg)

------

![slide22.jpg](slide22.jpg)

------

![slide23.jpg](slide23.jpg)

------

![slide24.jpg](slide24.jpg)